COVID-19 | Čigota Zlatibor - specijalna bolnica za bolesti štitaste žlezde i metabolizma

INTERFERENCE IN IMMUNOASSAY MEASUREMENTS OF TSH AND THYROID HORMONES AFTER VACCINE FOR COVID-19 OR COVID-19 DISEASE

Ustanova

Clinic of endocrinology, diabetes and diseases of Metabolism, University Clinical Centre, Belgrade, Serbia

Faculty of medicine, University of Belgrade, Serbia

Reference

Bolstad N, Warren DJ, Nustad K. Heterophilic antibody interference in immunometric assays. Best Practice & Research Clinical Endocrinology & Metabolism 2013; 27: 647–661. https://doi.org/10.1016/j.beem.2013.05.011

Başok Banu Işbilen. Understanding and managing biotin interference in immunoassays. Int J Med Biochem. 2020. https://doi.org/10.14744/ijmb.2020.48303

Kabiri P, Weiskirchen R, van Helden J. The biotin interference within interference suppressed immunoassays. J Clin Lab Anal 2021; 35: e23940. https://doi.org/10.1002/ jcla.23940

Sažetak

INTERFERENCE IN IMMUNOASSAY MEASUREMENTS OF TSH AND THYROID HORMONES AFTER VACCINE FOR COVID-19 OR COVID-19 DISEASE

Ključne reči

interference

COVID-19

TSH

Thyroid hormones

Medicinski glasnik

Autor

Read more about INTERFERENCE IN IMMUNOASSAY MEASUREMENTS OF TSH AND THYROID HORMONES AFTER VACCINE FOR COVID-19 OR COVID-19 DISEASE

THE IMPACT OF THE COVID-19 PANDEMIC ON THE INCIDENCE OF TYPE 1 DIABETES MELLITUS IN CHILDREN AND ADOLESCENTS IN THE GENERAL HOSPITAL “DR. LAZA K. LAZAREVIĆ”, ŠABAC

E-mail

milijanadamnjanovic77@gmail.com

Ustanova

Pediatrics department, General hospital “Dr Laza K. Lazarevic”, Šabac, Serbia

Center for disease control and prevention, Institute of Public Health Sabac, Šabac, Serbia

Reference

American Diabetes Association Professional Practice Committee; 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022. Diabetes Care 1 January 2022; 45 (Supplement_1): S17–S38. https://doi.org/10.2337/dc22-S002

Gomber A, Ward ZJ, Ross C, Owais M, Mita C, Yeh JM, Reddy CL, Atun R. Variation in the incidence of type 1 diabetes mellitus in children and adolescents by world region and country income group: A scoping review. PLOS Glob Public Health. 2022 Nov 9;2(11):

Mayer-Davis EJ, Kahkoska AR, Jefferies C, Dabelea D, Balde N, Gong CX, et al. ISPAD clinical practice consensus guidelines 2018: definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2018;19(Suppl 27):7–19

Sažetak

THE IMPACT OF THE COVID-19 PANDEMIC ON THE INCIDENCE OF TYPE 1 DIABETES MELLITUS IN CHILDREN AND ADOLESCENTS IN THE GENERAL
HOSPITAL “DR. LAZA K. LAZAREVIĆ”, ŠABAC

Ključne reči

Medicinski glasnik

Autor

Read more about THE IMPACT OF THE COVID-19 PANDEMIC ON THE INCIDENCE OF TYPE 1 DIABETES MELLITUS IN CHILDREN AND ADOLESCENTS IN THE GENERAL HOSPITAL “DR. LAZA K. LAZAREVIĆ”, ŠABAC

SIMILARITIES AND DIFFERENCES OF CARDIOVASCULAR COMPLICATIONS OF COVID-19 INFECTION AND COVID-19 VACCINATION

E-mail

adjenic74@gmail.com

Ustanova

Special Hospital for Thyroid Diseases and Metabolism Disorders, Zlatibor,

Reference

Saeed S, Tadic M, Larsen TH, Grassi G, Mancia G. Coronavirus disease 2019 and cardiovascular complications: focused clinical review. J Hypertens. 2021; 39(7): 1282–1292.

Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417–1418.

Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020; 17: 543–58.

Sažetak

SIMILARITIES AND DIFFERENCES OF CARDIOVASCULAR COMPLICATIONS OF COVID-19 INFECTION AND COVID-19 VACCINATION

Ključne reči

COVID-19

COVID-19 vaccination

cardiovascular complications

myocarditis

pericarditis

myocardial infarction

Medicinski glasnik

Autor

Read more about SIMILARITIES AND DIFFERENCES OF CARDIOVASCULAR COMPLICATIONS OF COVID-19 INFECTION AND COVID-19 VACCINATION

NEW ANTICOAGULANT THERAPY ASPECTS TO THE COVID-19 PATIENTS – FROM PROPHYLAXIS TO COMPLICATIONS TREATMENT THERAPY

E-mail

adjenic74@gmail.com

Ustanova

Special Hospital for Thyroid Diseases and Metabolism Disorders Zlatibor

Reference

D Atri, HK Siddiqi, J Lang, V Nauffal, DA Morrow, Bohula EA. COVID-19 for the cardiologist: a current review of the virology, clinical epidemiology, cardiac and other clinical manifestations and potential therapeutic strategies. JACC Basic Transl Sci. 202

Terpos I, Ntanasis-Stathopoulos I, Elalamy E, Kastritis TN, Sergentanis M, Politou T, et al. Hematological findings and complications of COVID-19. Am. J. Hematol. 2020; 95: 834–847. https://doi.org/10.1002/ajh.25829.

Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb. Res. 2020; 191: 9–14. https://doi.org/ 10.1016/j

Sažetak

NEW ANTICOAGULANT THERAPY ASPECTS TO THE COVID-19 PATIENTS – FROM PROPHYLAXIS TO COMPLICATIONS TREATMENT THERAPY

Ključne reči

COVID-19

D-dimer

venous thromboembolism

Pulmonary embolism

low molecular weight heparin

anticoagulant therapy.

Medicinski glasnik

2021

vol. 26, iss. 81

Autor

Đenić Aleksandar

Read more about NEW ANTICOAGULANT THERAPY ASPECTS TO THE COVID-19 PATIENTS – FROM PROPHYLAXIS TO COMPLICATIONS TREATMENT THERAPY

Pulmonary thromboembolism and pericardial effusion as cardiovascular complications of COVID–19 infection

E-mail

adjenic74@gmail.com

Ustanova

Special Hospital for Thyroid Diseases and Metabolism Disorders Zlatibor

Reference

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395 (10223): 497–506.

Al-Ani F, Chehade S, Lazo-Langner A. Thrombosis risk associated with COVID-19 infection. A scoping review. Thromb Res. 2020; 192: 152–160.

Danzi GB, Loffi M, Galeazzi G, Gherbesi E. Acute pulmonary embolism and COVID- 19 pneumonia: a random association? Eur Heart J. 2020; 41( 19):1858.

Sažetak

Pulmonary thromboembolism and pericardial effusion as cardiovascular complications of COVID–19 infection

Ključne reči

COVID-19

SARS-CoV-2

pulmonary thromboembolism

pericarditis

pericardial effusion

D-dimer

anticoagulant therapy